Article Text

Download PDFPDF
Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage
  1. Kristiina Ojamaa, MD,
  2. Piret Veerus, MD, PhD,
  3. Aleksei Baburin, MSc,
  4. Hele Everaus, MD, PhD and
  5. Kaire Innos, MD, PhD
  1. * Oncology Centre, East Tallinn Central Hospital, Tallinn;
  2. Faculty of Medicine, Tartu University, Tartu;
  3. Women’s Clinic, West Tallinn Central Hospital;
  4. § Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn; and
  5. Haematology-Oncology Clinics, Tartu University Hospital, Tartu, Estonia.
  1. Address correspondence and reprint requests to Kristiina Ojamaa, MD, Oncology Centre, East Tallinn Central Hospital, Pärnu St 104, 11312 Tallinn, Estonia. E-mail: kristiina.ojamaa{at}itk.ee.

Abstract

Objective The objective of the study was to examine temporal trends in ovarian cancer (OC) survival in Estonia during 1995 to 2009 in relation to age and stage.

Materials and Methods Estonian Cancer Registry data on all adult cases of primary OC diagnosed during 1995 to 2009 and followed up for vital status until 2014 were used to estimate relative survival ratios (RSRs). Cohort analysis was used to estimate 1-, 2-, and 5-year RSRs for patients diagnosed in 1995 to 1999, 2000 to 2004, and 2005 to 2009. Analysis was performed by age at diagnosis (<50; 50–59; 60–69; 70+ years) and stage (International Federation of Gynecology and Obstetrics 1988).

Results Among 2296 women included in the study, the age-adjusted 5-year RSR improved from 27% in 1995 to 1999 to 38% in 2005 to 2009. Survival increase of 10% units from 1995 to 1999 to 2005 to 2009 was seen for women aged 50 to 59 and 60 to 69 years. Among younger and older women, the respective changes were smaller. In 1995 to 1999, the difference in survival between the youngest and oldest age groups was 41% units. This decreased over the study period to 37% units. From 1995 to 1999 to 2005 to 2009, the 5-year RSR increased from 82% to 91% for stage I patients; from 48% to 67% for stage II patients; from 25% to 35% for stage III patients; and from 11% to 16% for stage IV patients.

Conclusions The study showed an improvement of OC survival in Estonia in all age and stage groups, but particularly among younger women and those with early stage disease. Slower progress among older women is of great concern.

  • Ovarian cancer
  • Relative survival
  • Age
  • Stage

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interests.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.